Manufacturer record
Casid Pharmaceuticals Private Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Casid Pharmaceuticals Private Limited (Tamil Nadu) were declared Not of Standard Quality between October 2025 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CL-24083, AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN AND MENTHOL SYRUP (exp Nov 2026). DTL, Puducherry (state lab) found it not of standard quality: Incorrect labelling. Listed in the November 2025 alert.
Records by type
2 records linked to Casid Pharmaceuticals Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN AND MENTHOL SYRUP | Batch CL-24083Mfg Dec 2024 · Exp Nov 2026 | Incorrect labellingLabelling | DTL, PuducherryState lab | Nov 2025 |
| Paracetamol Paediatric Oral Suspension IP (LOWFE-250) | Batch CL-24098Mfg Feb 2025 · Exp Jan 2027 | Failed in AssayAssay | DTL, PuducherryState lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.